David Koditek
About David Koditek
David Koditek is a scientist currently employed at CytomX Therapeutics in the San Francisco Bay Area, where he has worked since 2022. He has a diverse background in research, having held various positions at notable institutions including Gilead Sciences and the Mayo Clinic.
Work at CytomX Therapeutics
David Koditek has been employed at CytomX Therapeutics as a Scientist since 2022. His role involves contributing to the company's research and development efforts in the biotechnology sector. Prior to his current position, he served as an Associate Scientist at the same organization from 2021 to 2022. His work at CytomX Therapeutics is based in the San Francisco Bay Area, a hub for innovation and biotechnology.
Education and Expertise
David Koditek holds a Bachelor of Arts degree in Biochemistry and Cell Biology from the University of Colorado at Boulder, which he completed from 2000 to 2003. He further advanced his education by obtaining an MBA from Golden Gate University between 2010 and 2012. His educational background provides a strong foundation for his work in scientific research and management within the biotechnology industry.
Background
David Koditek has a diverse professional background in scientific research, having worked in various capacities across multiple organizations. He began his career as an Undergraduate Research Assistant at the University of Colorado Boulder from 2000 to 2002. He has also held positions at notable institutions such as the Mayo Clinic and Gilead Sciences, where he gained extensive experience in research and development.
Previous Positions in Research
Throughout his career, David Koditek has held several significant positions in research. He worked at Gilead Sciences for a total of nine years in various roles, including Senior Research Associate and Associate Scientist I. Additionally, he spent time at Applied Molecular Transport as an Associate Scientist and completed a Summer Undergraduate Research Fellowship at the Mayo Clinic. These roles have contributed to his expertise in the field.